Status:
TERMINATED
Study Evaluating GAP-486 on Heart Rhythm in Patients With Coronary Artery Disease
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions:
Arrhythmia
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to learn the effects of a test drug on heart rhythms, which may become life-threatening if left untreated, and to provide data to see if the drug is well tolerated and saf...
Eligibility Criteria
Inclusion
- Patients with or without ICDs (implantable cardioverter defibrillators)
- Patients undergoing an electrophysiology study for evaluation of ventricular rhythm
- Patients with a history of heart disease
Exclusion
- Patients with uncontrolled blood pressure
- Patients with certain cardiac risk factors
- Patients with significant kidney or liver problems
Key Trial Info
Start Date :
November 1 2005
Trial Type :
INTERVENTIONAL
End Date :
October 1 2006
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT00137332
Start Date
November 1 2005
End Date
October 1 2006
Last Update
December 10 2007
Active Locations (33)
Enter a location and click search to find clinical trials sorted by distance.
1
Sacramento, California, United States, 95819
2
San Francisco, California, United States, 94143
3
Washington D.C., District of Columbia, United States, 20010
4
Orlando, Florida, United States, 32803